Verastem | 8.57 -0.67 -7.25% | ||
| VSTM | |||
| 高 9.30 | 开 9.26 | 量 211.90万股 | 总市值 5.27亿 |
| 低 8.55 | 换 3.44% | 额 1853.19万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
OYang
07-24 19:33
#药闻简讯# $Verastem(VSTM)$ 已授予 VS-7375 快速通道指定，用于治疗 KRAS G12D 突变的局部晚期或转移性胰腺癌
6讨论 · 7赞
Verastem(VSTM)
08-14 05:05
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000921895-25-002213 Act: 34 Size: 25 KB 网页链接
Verastem(VSTM)
08-15 06:05
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000947871-25-000778 Act: 34 Size: 7 KB 网页链接
Verastem(VSTM)
08-14 05:05
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000921895-25-002214 Act: 34 Size: 24 KB 网页链接
Verastem(VSTM)
08-07 01:15
$Verastem(VSTM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000935836-25-000481 Act: 34 Size: 18 KB 网页链接
Verastem(VSTM)
09-19 06:25
$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-091362 Size: 4 KB 网页链接
Verastem(VSTM)
09-25 04:35
$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-092973 Size: 6 KB 网页链接
Verastem(VSTM)
08-14 20:15
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001415889-25-021716 Act: 34 Size: 10 KB 网页链接
Verastem(VSTM)
08-07 08:45
$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-074843 Size: 5 KB 网页链接
Verastem(VSTM)
07-29 04:35
$Verastem(VSTM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003208 Act: 34 Size: 17 KB 网页链接
Verastem(VSTM)
07-30 02:55
$Verastem(VSTM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000932471-25-001066 Act: 34 Size: 6 KB 网页链接
Verastem(VSTM)
07-30 04:15
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001641172-25-021361 Act: 34 Size: 9 KB 网页链接
JWZHAO
08-12 15:42
$Verastem(VSTM)$ 定价很规矩，商业化进度不错，下有保底了。The cost of a 28-day 网页链接
@JWZHAO : Verastem的投资逻辑 Verastem是一家专注RAS通路驱动癌症治疗的初创生物制药企业，核心资产是avutometinib（RAF+MEK） + defactinib（FAK）的治疗组合，目前进展最快的是KRAS突变的低级别浆液性卵巢癌（LGSOC），RAMP301试验已经进入三期，FDA给予突破性疗法认定并纳入优先审评，预计2025年提交NDA。
作用机制上，V...
作用机制上，V...
Verastem(VSTM)
09-08 19:05
$Verastem(VSTM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-25-088021 Act: 34 Size: 15 MB 网页链接
Verastem(VSTM)
08-13 04:35
$Verastem(VSTM)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001104659-25-076866 Act: 33 Size: 996 KB 网页链接
Verastem(VSTM)
08-13 05:05
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000312069-25-000525 Act: 34 Size: 6 KB 网页链接
Verastem(VSTM)
08-08 20:55
$Verastem(VSTM)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-25-075498 Act: 33 Size: 1 MB 网页链接
Verastem(VSTM)
09-19 06:15
$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-091361 Size: 4 KB 网页链接
Verastem(VSTM)
09-19 06:15
$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-091360 Size: 5 KB 网页链接
Verastem(VSTM)
08-14 18:25
$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-180304 Act: 34 Size: 165 KB 网页链接